JULIA ZHENG: Open Payments
NPI 1811509383 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$711 in 41 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $934 · 2025 $711
Food & beverage: $711
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $136 |
| PFIZER INC. | 4 | $74 |
| ABBVIE INC. | 4 | $74 |
| GlaxoSmithKline, LLC. | 4 | $63 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $51 |
| Aimmune Therapeutics, Inc. | 3 | $47 |
| Xeris Pharmaceuticals, Inc. | 2 | $37 |
| Novo Nordisk Inc | 2 | $34 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $32 |
| Ardelyx, Inc. | 1 | $19 |
Products named: AIRSUPRA, Kerendia, TRELEGY ELLIPTA, ZENPEP, PREVNAR 20, GVOKE HYPOPEN, BYETTA, NURTEC ODT.
Industry payments across AZ — which companies pay providers there.
